Pharma IQ | 12/16/2010
Lisa Miranda, President and CEO, Biobusiness Consulting, Inc., Vice President, Strategic Alliances and International Biobank Relations, Trans-Hit Biomarkers Inc., and Senior Advisor, Business Development, Bluechiip Ltd. joins Amber Scorah from Pharma IQ, to share her insights and thoughts on what she coins to be the "Age of Utilisation, Collaboration and Innovation" along with an overview of some of the key success factors for unearthing the promise of biospecimen research.
To continue reading this story Click Here
RECOMMENDED
MSD announces Phase III data on investigational treatment to lower LDL Cholesterol (LDL-C)
2025-11-17
AI for Pharma & Healthcare 2025
2025-06-18
Upcoming Events
SmartLab Exchange USA
April 20-21, 2026
The Logan, Philadelphia, USA
Register Now |
View Agenda |
Learn More